100 related articles for article (PubMed ID: 12970319)
1. Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes.
Modi J; Patel A; Terrell R; Tuttle RM; Francis GL
J Clin Endocrinol Metab; 2003 Sep; 88(9):4418-25. PubMed ID: 12970319
[TBL] [Abstract][Full Text] [Related]
2. Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults.
Gupta S; Patel A; Folstad A; Fenton C; Dinauer CA; Tuttle RM; Conran R; Francis GL
J Clin Endocrinol Metab; 2001 Mar; 86(3):1346-54. PubMed ID: 11238531
[TBL] [Abstract][Full Text] [Related]
3. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
4. Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid.
Gogali F; Paterakis G; Rassidakis GZ; Kaltsas G; Liakou CI; Gousis P; Neonakis E; Manoussakis MN; Liapi C
J Clin Endocrinol Metab; 2012 May; 97(5):1474-82. PubMed ID: 22399513
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
French JD; Weber ZJ; Fretwell DL; Said S; Klopper JP; Haugen BR
J Clin Endocrinol Metab; 2010 May; 95(5):2325-33. PubMed ID: 20207826
[TBL] [Abstract][Full Text] [Related]
6. Association of CD1a-positive dendritic cells with papillary thyroid carcinoma in thyroid fine-needle aspirations: a cytologic and immunocytochemical evaluation.
Pusztaszeri MP; Sadow PM; Faquin WC
Cancer Cytopathol; 2013 Apr; 121(4):206-13. PubMed ID: 23042745
[TBL] [Abstract][Full Text] [Related]
7. Clinical importance of vascular endothelial growth factor (VEGF) for papillary thyroid carcinomas.
Kilicarslan AB; Ogus M; Arici C; Pestereli HE; Cakir M; Karpuzoglu G
APMIS; 2003 Mar; 111(3):439-43. PubMed ID: 12752224
[TBL] [Abstract][Full Text] [Related]
8. Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer.
Lennard CM; Patel A; Wilson J; Reinhardt B; Tuman C; Fenton C; Blair E; Francis GL; Tuttle RM
Surgery; 2001 May; 129(5):552-8. PubMed ID: 11331447
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma.
Klein M; Vignaud JM; Hennequin V; Toussaint B; Bresler L; Plénat F; Leclère J; Duprez A; Weryha G
J Clin Endocrinol Metab; 2001 Feb; 86(2):656-8. PubMed ID: 11158026
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of vascular endothelial growth factor for thyroid neoplasms.
Huang SM; Lee JC; Wu TJ; Chow NH
World J Surg; 2001 Mar; 25(3):302-6. PubMed ID: 11343180
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and functional characterization of lymphocytes in autoimmune thyroiditis and in papillary carcinoma.
Mardente S; Lenti L; Lococo E; Consorti F; Della Rocca C; Romeo S; Misasi R; Antonaci A
Anticancer Res; 2005; 25(3c):2483-8. PubMed ID: 16080480
[TBL] [Abstract][Full Text] [Related]
12. [Immunohistochemical studies of mononuclear cellular infiltrates of papillary, follicular and anaplastic thyroid cancers].
Kornfehl J; Wilfing A; Hermann M
Laryngorhinootologie; 1994 Apr; 73(4):183-8. PubMed ID: 8011021
[TBL] [Abstract][Full Text] [Related]
13. BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.
Costa AM; Herrero A; Fresno MF; Heymann J; Alvarez JA; Cameselle-Teijeiro J; García-Rostán G
Clin Endocrinol (Oxf); 2008 Apr; 68(4):618-34. PubMed ID: 18070147
[TBL] [Abstract][Full Text] [Related]
14. Immune status of Fanconi anemia patients: decrease in T CD8 and CD56dim CD16+ NK lymphocytes.
Justo GA; Bitencourt MA; Pasquini R; Castelo-Branco MT; Almeida-Oliveira A; Diamond HR; Rumjanek VM
Ann Hematol; 2014 May; 93(5):761-7. PubMed ID: 24240977
[TBL] [Abstract][Full Text] [Related]
15. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.
Fugazzola L; Puxeddu E; Avenia N; Romei C; Cirello V; Cavaliere A; Faviana P; Mannavola D; Moretti S; Rossi S; Sculli M; Bottici V; Beck-Peccoz P; Pacini F; Pinchera A; Santeusanio F; Elisei R
Endocr Relat Cancer; 2006 Jun; 13(2):455-64. PubMed ID: 16728573
[TBL] [Abstract][Full Text] [Related]
16. Papillary carcinoma of the thyroid: evidence for a role for hepatocyte growth factor (HGF) in promoting tumour angiogenesis.
Scarpino S; D'Alena FC; Di Napoli A; Ballarini F; Prat M; Ruco LP
J Pathol; 2003 Feb; 199(2):243-50. PubMed ID: 12533838
[TBL] [Abstract][Full Text] [Related]
17. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
18. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women.
Merhi ZO; Durkin HG; Feldman J; Macura J; Rodriguez C; Minkoff H
Surg Obes Relat Dis; 2009; 5(2):165-71. PubMed ID: 18996763
[TBL] [Abstract][Full Text] [Related]
19. Is human leukocyte antigen-DR and intercellular adhesion molecule-1 expression on human thyrocytes constitutive in papillary thyroid cancer? Comparative studies in human thyroid xenografts in severe combined immunodeficient and nude mice.
Kawai K; Resetkova E; Enomoto T; Fornasier V; Volpé R
J Clin Endocrinol Metab; 1998 Jan; 83(1):157-64. PubMed ID: 9435434
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of infiltration and angiogenesis by thrombospondin-1 in papillary thyroid carcinoma.
Tanaka K; Sonoo H; Kurebayashi J; Nomura T; Ohkubo S; Yamamoto Y; Yamamoto S
Clin Cancer Res; 2002 May; 8(5):1125-31. PubMed ID: 12006528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
